ArticleBMC cancer2025

KIF20A as a driver of anti-PD-1 resistance via PD-L1 downregulation in NSCLC: a biomarker validation and tumor microenvironment analysis.

Tianyu Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.